Design
Review
Authors
Loading...
Shifting focus to theatre efficiency over drug selection may optimize savings; leaves open validation via prospective economic trials.
Key points are not available for this paper at this time.
W. L. Rowe (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: